ALNY Stock Analysis Overview
What this means: InvestorsObserver gives Alnylam Pharmaceuticals (ALNY) an overall rank of 28, which is below average. Alnylam Pharmaceuticals is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 28 means that 72% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
ALNY Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
ALNY Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
ALNY Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
ALNY Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
ALNY Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
ALNY Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
ALNY Stock Analysis Overview
What this means: InvestorsObserver gives Alnylam Pharmaceuticals (ALNY) an overall rank of 28, which is below average. Alnylam Pharmaceuticals is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 28 means that 72% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.